Internal Medicine, Endocrinology, Diabetes, & Metabolism · Stockbridge, GA
NPI
1164684700
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
226 Willis Dr
Stockbridge, GA, 30281
Phone (770) 389-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
4,770 services
Medicare patients, 2024
314
Average age 73
Drug cost, 2024
$2.4M
5,644 prescriptions
Company payments, 2025
$3,731
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shehzad M Topiwala was code J0897 (injection, denosumab, 1 mg), 900 times for 12 patients. In total Shehzad M Topiwala billed 4,770 services in 29 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 900 | 12 | $20.38 | $18K |
| 99214 Office E&M - Established | Office | 570 | 241 | $85.71 | $49K |
| 99213 Office E&M - Established | Office | 535 | 203 | $65.61 | $35K |
| 99457 E&M - Miscellaneous | Office | 400 | 65 | $36.78 | $15K |
| 95251 Test - Miscellaneous | Office | 395 | 86 | $25.37 | $10K |
| 99454 E&M - Miscellaneous | Office | 389 | 63 | $36.11 | $14K |
| 99458 E&M - Miscellaneous | Office | 300 | 61 | $29.95 | $8,986 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 213 | 40 | $48.57 | $10K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 188 | 36 | $37.40 | $7,032 |
| 76536 Ultrasound - Nonspecific | Office | 141 | 124 | $74.86 | $11K |
| 93923 Duplex Scan - Extremity Arteries | Office | 136 | 128 | $100.62 | $14K |
| 94690 Pulmonary Function Testing | Office | 126 | 110 | $33.47 | $4,218 |
| 95923 Electrical Nerve Conductivity | Office | 73 | 73 | $94.49 | $6,897 |
| 99204 Office E&M - New | Office | 50 | 50 | $116.98 | $5,849 |
| 99453 E&M - Miscellaneous | Office | 49 | 48 | $15.31 | $750 |
By year: 2022 $92K for 1,233 services; 2023 $133K for 2,027 services; 2024 $229K for 4,770 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shehzad M Topiwala prescribed most often to Medicare patients was Levothyroxine Sodium, with 516 prescriptions and refills. In total Shehzad M Topiwala wrote 5,644 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 516 | 1,346 | 177 | $5,135 |
| Ozempic Semaglutide | 425 | 592 | 121 | $540K |
| Mounjaro Tirzepatide | 258 | 298 | 61 | $311K |
| Atorvastatin Calcium Generic | 244 | 667 | 101 | $2,196 |
| Metformin Hcl Generic | 244 | 677 | 90 | $1,633 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 231 | 421 | 71 | $254K |
| Amlodipine Besylate Generic | 220 | 577 | 95 | $1,305 |
| Synthroid Levothyroxine Sodium | 168 | 391 | 53 | $16K |
| Jardiance Empagliflozin | 162 | 330 | 49 | $186K |
| Gvoke Hypopen 2-Pack Glucagon | 155 | 193 | 119 | $101K |
| Metformin Hcl Er Metformin Hcl | 130 | 358 | 48 | $1,523 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 116 | 267 | 49 | $19K |
| Tresiba Flextouch U-200 Insulin Degludec | 114 | 244 | 47 | $90K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 111 | 300 | 76 | $14K |
| Losartan Potassium Generic | 99 | 267 | 40 | $1,069 |
Brand drugs: 2,716 claims; generic drugs: 2,438 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shehzad M Topiwala $3,731 ($3,731 in general payments such as food, travel and fees) from 39 companies. The largest payer was Novo Nordisk Inc with $651.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 18 | $651 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $267 |
| Xeris Pharmaceuticals, Inc. | 9 | $264 |
| Lilly USA, LLC LLY | 9 | $225 |
| Sequel Med Tech, LLC | 5 | $205 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $195 |
| Madrigal Pharmaceuticals MDGL | 6 | $165 |
| Corcept Therapeutics CORT | 6 | $157 |
| Amgen Inc. AMGN | 8 | $148 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.